FDA DrugClass IINotable
FDA Recall: Naropin (ropivacaine hydrochloride Injection, USP), 0.5%, 100 mg per 20 mL (5 mg per mL), Twenty-fiv
Description
Presence of Particulate Matter: Hair was found in products
Hazard
Presence of Particulate Matter: Hair was found in products
Remedy
92,600 vials
Related Recalls
2026-07-29 · FDA_DRUG
FDA Recall: Lidocaine HCl Injection, USP, 2%, 100 mg per 5 mL (20 mg per mL), 25 Single Dose Vials, 5 mL per via
Fresenius Kabi USA, LLC
2026-07-29 · FDA_DRUG
FDA Recall: Xylocaine (lidocaine HCl Injection, USP), 1%, 200 mg per 20 mL (10 mg per mL), 25 Multiple-Dose Vial
Fresenius Kabi USA, LLC
2026-07-29 · FDA_DRUG
FDA Recall: Xylocaine (lidocaine HCl Injection, USP), 1%, 500 mg per 50 mL (10 mg per mL), 25 Multiple-Dose Vial
Fresenius Kabi USA, LLC
2026-07-29 · FDA_DRUG
FDA Recall: Glycopyrrolate Injection, USP, 1 mg per 5 mL (0.2 mg per mL), 25 x 5 mL fill in a 6.5 mL vial, Rx o
Fresenius Kabi USA, LLC